Upload
innovation-norway
View
281
Download
1
Tags:
Embed Size (px)
Citation preview
PHARMAQ The Blue Economy – sustainable Fisheries and
Aquaculture for Food Security - Jakarta, 27-11-2012
Kjersti Gravningen
PHARMAQ’s business idea
• We provide environmentally sound,
safe and efficacious health products
to the global aquaculture industry
through targeted research and the
commitment of dedicated people
Vaccination and disease control in Norwegian fish farming
Treatment Prevention
PHARMAQ in brief
• Head office in Norway
• Subsidiaries in the UK, Chile,
Turkey and Vietnam
• Distributors other countries
• 155 employees
• 20% of revenue allocated to
R&D (≈ USD 15 mill 2012)
• Export to >14 countries
• >60% market share
salmonids 2011
A knowledge driven company
PHARMAQ ASIA
PHARMAQ in Vietnam
• 100% owned by PHARMAQ AS
• Clinical R&D and S&M
• 16 employees
• Trained vaccination team
• Wet lab for clinical testing
• Diagnostic lab
Results– after vaccination of pangasius
against E. Ictaluri - field observation period
0,00
2,00
4,00
6,00
8,00
10,00
12,00
14,00
16,00
18,00
1 11 21 31
% m
ort
alit
y
Day post vaccination
0
5
10
15
20
25
30
35
40
45
1 11 21 31 41
% m
ort
alit
y
Day after vacciantion
R
V
R
R
V
Relevant experience in species and diseases
• Pangasius / catfish
• Asian Sea bass / Barramundi
• Tilapia
• Grouper
• Cobia
• Edwardsiella ictaliuri
• Aeromonas hydrophila
• Streptococcus agalactieae
• Streotococcus iniae
• Photobacterium damselae
• Flavobacterium /
Tenacibaculum sp.
• Vibrio sp
• VNN
Vaccination a good tool for the Blue economy
Vaccines increases
sustainability and
predictability
• Reduces mortality
• Reduces use of antibiotics
• Improve environment
• Improve growth
• Improve food safety
2010 2014
Grouper 7 20
Sea bass 5 8,5
Tilapia 492 1243
Catfish 495 2783
0
500
1000
1500
2000
2500
3000
3500
4000
4500
10
00
to
ns
Future production in Indonesia
Sugama 2011
– Collection of strains
– Clinical development
– Safety / Efficacy testing
– Field tests
– Sales
– Characterisation
– Process development
– Formulation
– Documentation
– Production
Vaccine development for new regions